株式会社極東書店トップ ＞ 商品一覧 ＞ Regulation of Biotechnological Risks in a Multi-Level System : An Analysis of the EU Regulation of Genome Edited Plants in light of WTO Law and CETA.
商品詳細
Regulation of Biotechnological Risks in a Multi-Level System : An Analysis of the EU Regulation of Genome Edited Plants in light of WTO Law and CETA.
・ISBN 978-3-032-02408-4 hard EUR 159.99
￥42,764.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Andersen, Elisabeth Anna Lümkea, |
|---|---|
| シリーズ | European Yearbook of International Economic Law |
| 出版社 | (Springer, GW) |
| 出版年月 | 2025.11 |
| ページ数 | 310 pp. |
| 言語 | ENG |
| ニュース番号 | ＜756-619 756-627＞ |
解説
This book offers an in-depth analysis of the EU regulation of genome edited plants and its compatibility with WTO law and the Comprehensive Economic Trade Agreement (CETA). It analyses in detail whether the EU authorisation procedures, labelling requirements and the EU's opt-out mechanism and its application to genome edited plants are compatible with the EU's obligations under the Agreement on Sanitary and Phytosanitary Measures (SPS Agreement), the Agreement on Technical Barriers to Trade (TBT Agreement), the General Agreement on Tariffs and Trade (GATT) and CETA. Based on this analysis, the EU Commission's proposal for a new regulation on plants produced by certain new genomic techniques is discussed. Also, the book provides suggestions to further improve the EU Commission's proposal. The book's analysis is not only relevant for legal researchers in the field of biotechnology and international economic law, but also discusses regulatory aspects that are highly relevant for the scientific and industrial sector involved in biotechnology.